Skip to main content
. 2021 Jan 3;9(1):6. doi: 10.1007/s40203-020-00066-7

Table 2.

ADMET properties of the ligands by SwissADME

Compound MW MlogP HBA HBD Lipinski violations GI absorption BBB permeant
Tariquidar (control) 646.73 g/mol 2.68 8 2 1 violation: MW > 500 Low No
Zosuquidar (control) 527.60 g/mol 3.66 7 1 1 violation: MW > 500 High Yes
Grossamide 624.68 g/mol 1.90 8 5 1 violation: MW > 500 Low No
Cannabisin A 594.61 g/mol 2.36 8 8 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin B 596.63 g/mol 1.53 8 8 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin C 610.65 g/mol 1.72 8 7 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin D 624.68 g/mol 1.90 8 6 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin E 642.69 g/mol 1.53 9 6 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin F 624.68 g/mol 2.22 8 5 1 violation: MW > 500 Low No
Cannabisin G 624.68 g/mol 2.22 8 6 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin M 596.63 g/mol 1.53 8 6 2 violations: MW > 500, NHorOH > 5 Low No
Cannabisin N 610.65 g/mol 1.72 8 5 1 violation: MW > 500 Low No

MW Molecular weight, HBA Num. H-bond acceptors, HBD Num. H-bond donors, BBB Blood brain barrier, GI Absorption Gastro intestinal absorption